Viewing Study NCT05289232


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-24 @ 9:44 PM
Study NCT ID: NCT05289232
Status: COMPLETED
Last Update Posted: 2023-05-16
First Post: 2022-03-02
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Prevalence and Complications of Suture in the ED
Sponsor: University of Monastir
Organization:

Study Overview

Official Title: Prevalence of Complications Post Sutured Wounds in the ED
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: included patients who had sutured wounds in the ED were asked about complications after suture .
Detailed Description: All patients using the emergency room of EPS Fattouma Bourguiba Monastir are welcomed by a resident in the suture room. After an inclusion, patients are cared for in the outpatient circuit and the suture will be done in the dedicated box. Before discharging the patient, instructions and standardized prescriptions are given to the patient such as standard prescriptions for local wound care, removal of stitches and verification of vaccination status.

The data relevant to this study are obtained prospectively from a detailed questionnaire in the annex and a telephone call and they are completed retrospectively with the data collected in the computerized medical record.

At the healing period, between 15 days and 45 days after the suture, the investigators called the patients back in order to know the evolution of the wound, the adherence to the instructions and the prescriptions, the quality of healing and the search for complications (infection , loose stitches, hematoma, etc.)

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: